CpG oligodeoxynucleotides do not require T(H1) cytokines to prevent eosinophilic airway inflammation in a murine model of asthma

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages 1258-1264

  Kline, Joel N ^a,c   Krieg, Arthur M ^a,b   Waldschmidt, Thomas J ^a   Ballas, Zuhair K ^a   Jain, Vipul ^a   Businga, Thomas R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA HEALTH CARE   (United States)

Author keywords

Asthma; CpG oligodeoxynucleotides; IFN ; IL 12; Murine; T(H1)

Indexed keywords

BLOCKING ANTIBODY; CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; OLIGODEOXYNUCLEOTIDE;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL PROTECTION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; EOSINOPHILIA; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; TH1 CELL; TREATMENT OUTCOME;

EID: 0033429176     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70022-9     Document Type: Article

References (29)

1. 1. National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; 1997. Publication No. 97-4051.
2. 2. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin 5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993;147:540-7.
3. 3. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
4. 4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
5. 5. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
6. 6. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9.
7. 7. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996;156:4570-5.
8. 8. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-5.
9. 9. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998;160:2555-9.
10. 10. Dalton D, Pitts-Meek S, Keshav S, Figari I, Bradley A, Stewart T. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739-45.
11. 11. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, et al. IL-12-deficient mice are defective in IFN gamma production and type I cytokine responses. Immunity 1996;4:471-81.
12. 12. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, et al. Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1918-21.
13. 13. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 1996;156:1442-7.
14. 14. Spitalny G, Havell E. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 1984;159:1560-5.
15. 15. Rosner B. Fundamentals of biostatistics. 4th ed. Washington (DC): Duxbury Press; 1995.
16. 16. Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 1997;84:185-93.
17. 17. Wooldridge JE, Ballas Z, Krieg AM, Weiner GJ. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood 1997;89:2994-8.
18. 18. Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA 1997;94:10833-7.
19. 19. Yi AK, Hornbeck P, Lafrenz DE, Krieg AM. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xl. J Immunol 1996;157:4918-25.
20. 20. Krieg AM, Yi AK, Schorr J, Davis HL. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 1998;6:23-7.
21. 21. Li XM, Chopra RK, Chou TY, Schofield BH, Wills-Karp M, Huang SK. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996;157:3216-9.
22. 22. Kips JC, Brusselle GG, Joos GF, Peleman RA, Devos RR, Tavernier JH, et al. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 1995;107:115-8.
23. 23. Wynn T, Jankovic D, Hieny S, Zioncheck K, Jardieu P, Cheever A, et al. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J Immunol 1995;154:3999-4009.
24. 24. Hunter CA, Gabriel KE, Radzanowski T, Neyer LE, Remington JS. Type I interferons enhance production of IFN-gamma by NK cells. Immunol Lett 1997;59:1-5.
25. 25. Brinkmann V, Geiger T, Alkan S, Heusser C. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 1992;178:1655-63.
26. 26. McRae BL, Picker LJ, van Seventer GA. Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors. Eur J Immunol 1997;27:2650-6.
27. 27. Vieillard V, Cremer I, Lauret E, Rozenbaum W, Debre P, Autran B, et al. Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proc Natl Acad Sci USA 1997;94:11595-600.
28. 28. Bartholome EJ, Willems F, Crusiaux A, Thielemans K, Schandene L, Goldman M. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion. J Interferon Cytokine Res 1999;19:471-8.
29. 29. McRae BL, Semnani RT, Hayes MP, van Seventer GA. Type 1 IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 1998;160:4298-304.